• Study on EXL01 for Preventing Crohn’s Disease Recurrence After Surgery in Patients

    Recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Study of Cetuximab and Paclitaxel for Patients with Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma After Pembrolizumab Treatment

    Recruiting

    2 1 1 1
    Investigated Drugs:
    Spain
  • Study on Metformin and Colchicine for Patients with Long COVID Symptoms

    Recruiting

    3 1 1
    Investigated Diseases:
    The Netherlands
  • Study on the Effectiveness and Safety of Nizubaglustat in Patients with Niemann-Pick Type C, GM1, or GM2 Gangliosidosis

    Recruiting

    3 1
    Investigated Drugs:
    France Germany Italy Portugal Spain Sweden
  • Study Comparing Gemcitabine and Paclitaxel with Drug Combination for Patients with Advanced Pancreatic Cancer

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Italy
  • Study on Sotagliflozin for Improving Symptoms in Patients with Hypertrophic Cardiomyopathy

    Recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Belgium Bulgaria Croatia Czechia France Germany +7
  • Study on Eltrekibart and Mirikizumab for Adults with Moderate to Severe Ulcerative Colitis

    Recruiting

    2 1
    Investigated Diseases:
    Belgium Croatia Czechia Denmark France Germany +8
  • Study on the Safety and Effectiveness of Parecoxib and Sodium Chloride for Patients Hospitalized with Spontaneous Subarachnoid Hemorrhage

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia
  • Study of Tezepelumab effects on airway barrier function in patients with severe asthma, with or without chronic rhinosinusitis with nasal polyps

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Austria
  • Study of drug combinations including cisplatin, carboplatin, doxorubicin, fluorouracil, vincristine, etoposide, irinotecan, gemcitabine, oxaliplatin and sorafenib for children with hepatoblastoma or hepatocellular carcinoma

    Recruiting

    3 1 1 1
    Austria Belgium Czechia France Germany Ireland +4

powered by